prednisone has been researched along with 2019 Novel Coronavirus Disease in 98 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the influence of prednisone on inflammatory biomarkers in a previous multicenter, randomized, placebo-controlled trial that compared a 7-day treatment course of 50-mg prednisone to placebo in patients hospitalized with community-acquired pneumonia." | 9.41 | Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial. ( Blum, CA; Blum, MR; Briel, M; Cesana-Nigro, N; Christ-Crain, M; Mueller, B; Raess, N; Rodondi, N; Schaedelin, S; Schuetz, P; Urwyler, SA; Winzeler, B, 2021) |
| "BACKGROUND Autoimmune pancreatitis (AIP) is a rare, steroid-responsive disease of the pancreas." | 5.56 | High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). ( Kapoor, S; Liaquat, H; Matin, A; Shupp, B, 2020) |
| " We investigated the influence of prednisone on inflammatory biomarkers in a previous multicenter, randomized, placebo-controlled trial that compared a 7-day treatment course of 50-mg prednisone to placebo in patients hospitalized with community-acquired pneumonia." | 5.41 | Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial. ( Blum, CA; Blum, MR; Briel, M; Cesana-Nigro, N; Christ-Crain, M; Mueller, B; Raess, N; Rodondi, N; Schaedelin, S; Schuetz, P; Urwyler, SA; Winzeler, B, 2021) |
| "Patients with aggressive B-cell lymphoma and MYC rearrangement at fluorescence in situ hybridization exhibit poor outcome after R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone)." | 4.12 | Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. ( Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L, 2022) |
| "Patients who develop COVID-19 after kidney transplantation are at risk of acute kidney injury, and their prednisone, immunosuppressant, and gamma globulin treatment must be adjusted according to their condition." | 3.96 | Novel coronavirus infection and acute kidney injury in two renal transplant recipients: a case report. ( Cheng, Q; Dai, N; Ge, Q; Guo, W; Li, C; Li, Q; Li, S; Shen, N; Wang, J; Zeng, L; Zhao, Z; Zhu, L, 2020) |
| "2%) were subject to dosing adjustments." | 3.01 | The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma. ( Brown, AB; Carty, SA; Kaminski, MS; Phillips, TJ; Runge, JS; Wilcox, RA, 2023) |
| "After the first discharge, she got a recurrence of COVID-19 during her home isolation, and then returned to hospital and continued the previous therapy." | 2.66 | Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. ( Cao, J; Fan, L; He, F; Hu, K; Lei, M; Luo, Q; Qin, S; Shao, X; Yang, L; Yu, N, 2020) |
| " No moderate/severe adverse events attributable to the vaccine were observed." | 1.91 | Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. ( Aikawa, NE; Barbas, CV; Bonfa, E; Caparbo, VF; Dagostin, MA; Fusco, SRG; Kupa, LVK; Martins, CCMF; Martins, VAO; Medeiros-Ribeiro, AC; Pasoto, SG; Pereira, RMR; Saad, CGS; Sales, LP; Shinjo, SK; Silva, CA; Yuki, EFN, 2023) |
| "Hypertension was associated with mechanical ventilation (8." | 1.91 | Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective. ( Cortez, KJC; Del Rosario, AG; Gutierrez-Rubio, AKM; Lichauco, JJT; Rivera-Go, ICT; Salido, EO; Suilan, KEA; Villo, JGB; Zamora-Abrahan, GT, 2023) |
| "To review the drug-drug interactions between tacrolimus and lopinavir/ritonavir in 23 patients who received solid organ transplant during the first wave of COVID-19 and to determine the efficacy as well as safety of prednisone monotherapy." | 1.91 | Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir. ( Ambrosioni, J; Arranz, N; Bodro, M; Brunet, M; Castel, MÁ; Cofan, F; Crespo, G; Diekmann, F; Farrero, M; Forner, A; Gonzalez-García, R; LLigoña, A; Marcos, MÁ; Miró, JM; Moreno, A; Rodríguez-García, M; Roma, JR; Ruiz, P; Soy, D; Tuset, M, 2023) |
| "The impact of the coronavirus disease 2019 (COVID-19) pandemic has globally challenged health services, especially because when the pandemic first reached Mexico, in February 2020, there was no known effective and safe treatment." | 1.91 | Outpatient treatment of COVID-19: an experience with 552 cases in Mexico. ( Muñoz-Cordero, B; Romero-Cabello, R; Romero-Feregrino, R; Sevilla-Fuentes, S, 2023) |
| "Pemphigus is not a contraindication to vaccination, although it may be worse or present as a first onset." | 1.91 | Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report. ( Khalayli, N; Kudsi, M; Omar, A, 2023) |
| "Reactive arthritis was diagnosed in 1 patient who presented with swelling in both hands and wrists 2 days after being diagnosed with COVID-19." | 1.72 | Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series. ( Aung, T; Ballester, A; Cheav, S; Chen, C; Metyas, S, 2022) |
| "To report a case of non-arteritic anterior ischemic optic neuropathy (NAAION) with macular star after receiving the second dose of SARS-CoV-2 vaccination." | 1.72 | Non-arteritic Anterior Ischemic Optic Neuropathy with Macular Star following COVID-19 Vaccination. ( Elhusseiny, AM; Sallam, AB; Sanders, RN; Siddiqui, MZ, 2022) |
| " Furthermore, incremental increases in the dosage of SCs were associated with a greater risk for these outcomes." | 1.72 | Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database. ( Acharya, NR; Akpandak, I; Arnold, BF; Chen, EM; Miller, DC; Sun, Y, 2022) |
| "A total of 164 ARD patients who were coronavirus disease 2019 (COVID-19) poor/non-responders (negative anti-SARS-CoV-2 S1/S2 IgG and/or neutralizing antibodies-NAb) to the third dose of Sinovac-CoronaVac received an additional heterologous dose of mRNA (BNT162b2) 3 months after last dose." | 1.72 | Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine. ( Aikawa, NE; Andrade, DCO; Antonangelo, L; Bonfa, E; Chasin, ACS; Fusco, SRG; Kupa, LVK; Leon, EP; Lopes, MH; Luppino-Assad, AP; Medeiros-Ribeiro, AC; Pasoto, SG; Pereira, RMR; Saad, CGS; Sampaio-Barros, PD; Shimabuco, AY; Shinjo, SK; Silva, CA; Yuki, EFN, 2022) |
| "Among patients, 56% had juvenile idiopathic arthritis (JIA), 29% juvenile systemic lupus erythematosus (JSLE), and 15% juvenile dermatomyositis (JDM)." | 1.72 | COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: mental health issues and life conditions. ( Aikawa, NE; Buscatti, IM; Campos, LMMA; Casella, CB; Elias, AM; Gualano, B; Helito, AC; Ihara, BP; Kozu, KT; Lindoso, LM; Pedroso, CAA; Pereira, RMR; Polanczyk, GV; Queiroz, LB; Setoue, DND; Sieczkowska, SM; Silva, CAA; Simon, JR; Strabelli, CAA; Tanigava, NY; Viana, VSL, 2022) |
| " Data about the immunogenicity and adverse effects of the vaccine on patients with systemic autoimmune rheumatic diseases (SARDs) is emerging." | 1.72 | Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients. ( Gepstein, R; Halperin, T; Kimhi, O; Kivity, S; Levy, Y; Naser, R; Parikh, R; Pri-Paz Basson, Y; Tartakover Matalon, S; Tayer-Shifman, OE; Ziv, A; Ziv-Baran, T, 2022) |
| "However, acute partial transverse myelitis (APTM) is rare adverse events following received COVID-19 vaccines." | 1.72 | A case report of possible concurrent vasculitis in vertebral bodies and partial transverse myelitis following COVID-19 vaccination. ( Chen, Y; Li, Y; Zhan, T, 2022) |
| "To present an unusual case of recurrent multiple evanescent white dot syndrome (MEWDS) following the coronavirus 2019 (Covid-19) vaccination." | 1.62 | Presumed Recurrent MEWDS following Covid-19 Vaccination. ( Shen, W; Xu, Y, 2021) |
| "The neurologic manifestations of coronavirus disease 2019 (COVID-19) are wide-ranging, including various cranial neuropathies, beyond anosmia and dysgeusia, the exact neuropathological mechanism of which are yet unknown." | 1.62 | Stridor Due to Cranial Nerve X Palsy Progressing to Polyneuropathy in a Teenager With COVID-19. ( Chelius, D; Dean, A; Marri, K; Said, A, 2021) |
| "To describe a case of bilateral sudden sensorineural hearing loss (SSNHL) and intralabyrinthine hemorrhage in a patient with COVID-19." | 1.62 | Bilateral Sudden Sensorineural Hearing Loss and Intralabyrinthine Hemorrhage in a Patient With COVID-19. ( Chern, A; Famuyide, AO; Lalwani, AK; Moonis, G, 2021) |
| "We report on a patient with recurrence of anti-GBM disease after SARS-CoV-2 infection." | 1.62 | SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report. ( Cejna, M; Lhotta, K; Soleiman, A; Sprenger-Mähr, H; Winkler, A; Zitt, E, 2021) |
| "We report on the development of minimal change disease (MCD) with nephrotic syndrome and acute kidney injury (AKI), shortly after first injection of the BNT162b2 COVID-19 vaccine (Pfizer-BioNTech)." | 1.62 | Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. ( Fytlovich, S; Lebedev, L; Levin-Iaina, N; Sapojnikov, M; Tobar, A; Varadi-Levi, R; Wechsler, A; Yagil, Y; Zamir, D, 2021) |
| "Myalgia is fairly common in the prodromal phase of the viral illness which self-resolves." | 1.62 | COVID-19 IgG-related autoimmune inflammatory necrotizing myositis. ( Ayesha, B; Koyoda, S; Veyseh, M, 2021) |
| "BACKGROUND Autoimmune pancreatitis (AIP) is a rare, steroid-responsive disease of the pancreas." | 1.56 | High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). ( Kapoor, S; Liaquat, H; Matin, A; Shupp, B, 2020) |
| "We report a case of concurrent tonic pupil and trochlear nerve palsy in this context." | 1.56 | Concurrent tonic pupil and trochlear nerve palsy in COVID-19. ( Corrales-Benítez, Á; Ordás, CM; Pastor-Vivas, AI; Villacieros-Álvarez, J, 2020) |
| "In three patients, facial palsy was the first symptom." | 1.56 | Peripheral facial nerve palsy associated with COVID-19. ( Afonso, L; Araujo, A; Coutinho, R; Espíndola, O; Leite, AC; Lima, MA; Oliveira, HS; Silva, MTT; Soares, CN, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 98 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zipursky, JS | 1 |
| Croitoru, D | 1 |
| Xu, Y | 1 |
| Shen, W | 1 |
| Hall, VG | 2 |
| Ferreira, V | 1 |
| Kumar, D | 2 |
| Humar, A | 2 |
| Kaviani, A | 1 |
| Khansari Nejad, N | 1 |
| Akour, A | 1 |
| AlMuhaissen, SA | 1 |
| Nusair, MB | 1 |
| Al-Tammemi, AB | 1 |
| Mahmoud, NN | 1 |
| Jalouqa, S | 1 |
| Alrawashdeh, MN | 1 |
| Shanahan, JP | 1 |
| Moore, CM | 1 |
| Kampf, JW | 1 |
| Szymczak, NK | 1 |
| Guo, J | 1 |
| Wang, H | 1 |
| Luo, Y | 1 |
| An, H | 1 |
| Zhang, Z | 2 |
| Liu, G | 1 |
| Li, J | 2 |
| Metcalfe, GD | 1 |
| Smith, TW | 1 |
| Hippler, M | 1 |
| Ayala Izurieta, JE | 1 |
| Márquez, CO | 1 |
| García, VJ | 1 |
| Jara Santillán, CA | 1 |
| Sisti, JM | 1 |
| Pasqualotto, N | 1 |
| Van Wittenberghe, S | 1 |
| Delegido, J | 1 |
| Kubo, Y | 1 |
| Kitagawa, Y | 1 |
| Miyazaki, T | 1 |
| Sohda, M | 1 |
| Yamaji, T | 1 |
| Sakai, M | 1 |
| Saeki, H | 1 |
| Nemoto, K | 1 |
| Oyama, T | 2 |
| Muto, M | 1 |
| Takeuchi, H | 1 |
| Toh, Y | 1 |
| Matsubara, H | 1 |
| Mano, M | 1 |
| Kono, K | 1 |
| Kato, K | 1 |
| Yoshida, M | 1 |
| Kawakubo, H | 1 |
| Booka, E | 1 |
| Yamatsuji, T | 1 |
| Kato, H | 1 |
| Ito, Y | 1 |
| Ishikawa, H | 1 |
| Ishihara, R | 1 |
| Tsushima, T | 1 |
| Kawachi, H | 1 |
| Kojima, T | 1 |
| Kuribayashi, S | 1 |
| Makino, T | 1 |
| Matsuda, S | 1 |
| Doki, Y | 1 |
| Ma, P | 1 |
| Tang, X | 1 |
| Zhang, L | 2 |
| Wang, X | 2 |
| Wang, W | 1 |
| Zhang, X | 2 |
| Wang, S | 3 |
| Zhou, N | 1 |
| Dodd, J | 1 |
| Jordan, R | 1 |
| Makhlina, M | 1 |
| Pesco Koplowitz, L | 1 |
| Koplowitz, B | 1 |
| Barnett, K | 1 |
| Yang, WH | 1 |
| Spana, C | 1 |
| Buchanan, SW | 1 |
| Mafa-Attoye, T | 1 |
| Dunfield, K | 1 |
| Thevathasan, NV | 1 |
| Isaac, ME | 1 |
| Wu, X | 3 |
| Huang, JW | 1 |
| Su, BK | 1 |
| Yuan, L | 1 |
| Zheng, WQ | 1 |
| Zhang, H | 3 |
| Zheng, YX | 1 |
| Zhu, W | 1 |
| Chou, PT | 1 |
| Manso, AP | 1 |
| De Morais, DC | 1 |
| Yamamoto, K | 2 |
| Owen, G | 1 |
| de Carvalho, RM | 1 |
| Palma-Dibb, RG | 1 |
| Brown, JC | 1 |
| Yang, S | 2 |
| Mire, EF | 1 |
| Miele, L | 1 |
| Ochoa, A | 1 |
| Zabaleta, J | 1 |
| Katzmarzyk, PT | 1 |
| Moi, CT | 1 |
| Bhowmick, S | 1 |
| Qureshi, M | 1 |
| Wang, K | 1 |
| Feng, B | 1 |
| Yang, Y | 2 |
| Chen, Y | 2 |
| Wang, Y | 2 |
| Yang, L | 2 |
| Jiang, K | 1 |
| James, TD | 1 |
| Chaturvedi, V | 1 |
| Postiglione, WM | 1 |
| Chakraborty, RD | 1 |
| Yu, B | 1 |
| Tabiś, W | 1 |
| Hameed, S | 1 |
| Biniskos, N | 1 |
| Jacobson, A | 1 |
| Zhou, H | 1 |
| Greven, M | 1 |
| Ferry, VE | 1 |
| Leighton, C | 1 |
| Wu, F | 1 |
| Lei, H | 1 |
| Chen, G | 1 |
| Chen, C | 2 |
| Song, Y | 1 |
| Cao, Z | 1 |
| Zhang, C | 3 |
| Zhou, J | 1 |
| Lu, Y | 2 |
| Pappone, C | 1 |
| Santinelli, V | 1 |
| Mecarocci, V | 1 |
| Tondi, L | 1 |
| Ciconte, G | 1 |
| Manguso, F | 1 |
| Sturla, F | 1 |
| Vicedomini, G | 1 |
| Micaglio, E | 1 |
| Anastasia, L | 1 |
| Pica, S | 1 |
| Camporeale, A | 1 |
| Lombardi, M | 1 |
| Shieh, PB | 1 |
| Elfring, G | 1 |
| Trifillis, P | 1 |
| Santos, C | 1 |
| Peltz, SW | 1 |
| Parsons, JA | 1 |
| Apkon, S | 1 |
| Darras, BT | 1 |
| Campbell, C | 1 |
| McDonald, CM | 1 |
| Galaviz, KI | 1 |
| Shah, NS | 1 |
| Gutierrez, M | 1 |
| Collins, LF | 1 |
| Lahiri, CD | 1 |
| Moran, CA | 1 |
| Szabo, B | 1 |
| Sumitani, J | 1 |
| Rhodes, J | 1 |
| Marconi, VC | 1 |
| Nguyen, ML | 1 |
| Cantos, VD | 1 |
| Armstrong, WS | 1 |
| Colasanti, JA | 1 |
| Dean, A | 1 |
| Said, A | 1 |
| Marri, K | 1 |
| Chelius, D | 1 |
| Funakoshi, Y | 1 |
| Yakushijin, K | 1 |
| Ohji, G | 1 |
| Hojo, W | 1 |
| Sakai, H | 1 |
| Watanabe, M | 1 |
| Saeki, M | 1 |
| Hirakawa, Y | 1 |
| Sakai, R | 1 |
| Matsumoto, S | 1 |
| Mizutani, Y | 1 |
| Kitao, A | 1 |
| Miyata, Y | 1 |
| Saito, Y | 1 |
| Kawamoto, S | 1 |
| Ito, M | 1 |
| Nishimura, M | 1 |
| Imamura, Y | 1 |
| Kiyota, N | 1 |
| Matsuoka, H | 1 |
| Mori, Y | 1 |
| Minami, H | 1 |
| Lavilla Olleros, C | 1 |
| Ausín García, C | 1 |
| Bendala Estrada, AD | 1 |
| Muñoz, A | 1 |
| Wikman Jogersen, PE | 1 |
| Fernández Cruz, A | 1 |
| Giner Galvañ, V | 1 |
| Vargas, JA | 1 |
| Seguí Ripoll, JM | 1 |
| Rubio-Rivas, M | 1 |
| Miranda Godoy, R | 1 |
| Mérida Rodrigo, L | 1 |
| Fonseca Aizpuru, E | 1 |
| Arnalich Fernández, F | 1 |
| Artero, A | 1 |
| Loureiro Amigo, J | 1 |
| García García, GM | 1 |
| Corral Gudino, L | 1 |
| Jiménez Torres, J | 1 |
| Casas-Rojo, JM | 1 |
| Millán Núñez-Cortés, J | 1 |
| Zlotnik, Y | 1 |
| Gadoth, A | 1 |
| Abu-Salameh, I | 1 |
| Horev, A | 1 |
| Novoa, R | 1 |
| Ifergane, G | 1 |
| Runge, JS | 1 |
| Brown, AB | 1 |
| Phillips, TJ | 1 |
| Kaminski, MS | 1 |
| Carty, SA | 1 |
| Wilcox, RA | 1 |
| Metyas, S | 1 |
| Aung, T | 1 |
| Ballester, A | 1 |
| Cheav, S | 1 |
| Ugarte-Gil, MF | 1 |
| Alarcón, GS | 1 |
| Izadi, Z | 2 |
| Duarte-García, A | 1 |
| Reátegui-Sokolova, C | 1 |
| Clarke, AE | 1 |
| Wise, L | 1 |
| Pons-Estel, GJ | 1 |
| Santos, MJ | 1 |
| Bernatsky, S | 1 |
| Ribeiro, SLE | 1 |
| Al Emadi, S | 1 |
| Sparks, JA | 2 |
| Hsu, TY | 1 |
| Patel, NJ | 1 |
| Gilbert, EL | 1 |
| Valenzuela-Almada, MO | 1 |
| Jönsen, A | 1 |
| Landolfi, G | 2 |
| Fredi, M | 2 |
| Goulenok, T | 1 |
| Devaux, M | 1 |
| Mariette, X | 1 |
| Queyrel, V | 1 |
| Romão, VC | 1 |
| Sequeira, G | 1 |
| Hasseli, R | 1 |
| Hoyer, B | 1 |
| Voll, RE | 1 |
| Specker, C | 1 |
| Baez, R | 1 |
| Castro-Coello, V | 1 |
| Maldonado Ficco, H | 1 |
| Reis Neto, ET | 1 |
| Ferreira, GAA | 1 |
| Monticielo, OAA | 1 |
| Sirotich, E | 2 |
| Liew, J | 1 |
| Hausmann, J | 1 |
| Sufka, P | 2 |
| Grainger, R | 2 |
| Bhana, S | 2 |
| Costello, W | 2 |
| Wallace, ZS | 2 |
| Jacobsohn, L | 2 |
| Taylor, T | 1 |
| Ja, C | 1 |
| Strangfeld, A | 2 |
| Mateus, EF | 2 |
| Hyrich, KL | 2 |
| Carmona, L | 2 |
| Lawson-Tovey, S | 2 |
| Kearsley-Fleet, L | 1 |
| Schäfer, M | 1 |
| Machado, PM | 2 |
| Robinson, PC | 2 |
| Gianfrancesco, M | 2 |
| Yazdany, J | 2 |
| Cvietusa, PJ | 1 |
| Goodrich, GK | 1 |
| Steiner, JF | 1 |
| Shoup, JA | 1 |
| King, DK | 1 |
| Ritzwoller, DP | 1 |
| Shetterly, SM | 1 |
| Bender, BG | 1 |
| Aikawa, NE | 7 |
| Kupa, LVK | 5 |
| Medeiros-Ribeiro, AC | 6 |
| Saad, CGS | 5 |
| Yuki, EFN | 5 |
| Pasoto, SG | 5 |
| Rojo, PT | 1 |
| Pereira, RMR | 6 |
| Shinjo, SK | 5 |
| Sampaio-Barros, PD | 4 |
| Andrade, DCO | 3 |
| Halpern, ASR | 2 |
| Fuller, R | 2 |
| Souza, FHC | 2 |
| Guedes, LKN | 2 |
| Assad, APL | 2 |
| Moraes, JCB | 2 |
| Lopes, MRU | 1 |
| Martins, VAO | 4 |
| Betancourt, L | 1 |
| Ribeiro, CT | 1 |
| Sales, LP | 4 |
| Bertoglio, IM | 1 |
| Bonoldi, VLN | 1 |
| Mello, RLP | 1 |
| Balbi, GGM | 1 |
| Sartori, AMC | 1 |
| Antonangelo, L | 2 |
| Silva, CA | 6 |
| Bonfa, E | 6 |
| Elhusseiny, AM | 1 |
| Sanders, RN | 1 |
| Siddiqui, MZ | 1 |
| Sallam, AB | 1 |
| Ferreri, AJM | 1 |
| Angelillo, P | 1 |
| Erbella, F | 1 |
| Cattaneo, C | 1 |
| Verga, L | 1 |
| Lleshi, A | 1 |
| Allione, B | 1 |
| Ponzoni, M | 1 |
| Facchetti, F | 1 |
| Pagani, C | 1 |
| Foppoli, M | 1 |
| Pecciarini, L | 1 |
| Sassone, M | 1 |
| Steffanoni, S | 1 |
| Flospergher, E | 1 |
| Rossi, G | 1 |
| Spina, M | 1 |
| Re, A | 1 |
| Sun, Y | 1 |
| Miller, DC | 1 |
| Akpandak, I | 1 |
| Chen, EM | 1 |
| Arnold, BF | 1 |
| Acharya, NR | 1 |
| Fusco, SRG | 4 |
| Chasin, ACS | 1 |
| Shimabuco, AY | 3 |
| Luppino-Assad, AP | 1 |
| Leon, EP | 1 |
| Lopes, MH | 2 |
| Ihara, BP | 1 |
| Lindoso, LM | 1 |
| Setoue, DND | 1 |
| Tanigava, NY | 1 |
| Helito, AC | 1 |
| Simon, JR | 1 |
| Viana, VSL | 1 |
| Strabelli, CAA | 1 |
| Pedroso, CAA | 1 |
| Sieczkowska, SM | 1 |
| Kozu, KT | 1 |
| Elias, AM | 1 |
| Buscatti, IM | 1 |
| Gualano, B | 1 |
| Queiroz, LB | 1 |
| Casella, CB | 1 |
| Polanczyk, GV | 1 |
| Silva, CAA | 1 |
| Campos, LMMA | 1 |
| Pri-Paz Basson, Y | 1 |
| Tayer-Shifman, OE | 1 |
| Naser, R | 1 |
| Tartakover Matalon, S | 1 |
| Kimhi, O | 1 |
| Gepstein, R | 1 |
| Halperin, T | 1 |
| Ziv-Baran, T | 1 |
| Ziv, A | 1 |
| Parikh, R | 1 |
| Kivity, S | 1 |
| Levy, Y | 1 |
| G S Saad, C | 1 |
| S R Silva, M | 1 |
| C B Moraes, J | 1 |
| G Schainberg, C | 1 |
| Gonçalves, CR | 1 |
| F N Yuki, E | 1 |
| G Pasoto, S | 1 |
| V K Kupa, L | 1 |
| K Aoyama, R | 1 |
| S R Araujo, C | 1 |
| Kilani, Y | 1 |
| Sohail, H | 1 |
| Lim, CY | 1 |
| Payette, A | 1 |
| Kamal, SAF | 1 |
| Afzal, A | 1 |
| Khan, T | 1 |
| Paracha, N | 1 |
| Muppidi, MR | 1 |
| Sittler, D | 1 |
| Li, Y | 2 |
| Zhan, T | 1 |
| Borba, EF | 1 |
| Miossi, R | 1 |
| Bonfiglioli, KR | 1 |
| Domiciano, DS | 1 |
| Seguro, LPC | 1 |
| Goldenstein-Schainberg, C | 1 |
| Giardini, HAM | 1 |
| Silva, HC | 1 |
| Villamarin, LEB | 1 |
| Novellino, RS | 1 |
| Araújo, CSR | 1 |
| Silva, MSR | 1 |
| Filho, DMN | 1 |
| Duarte, AJS | 1 |
| Kallas, EG | 1 |
| Owczarczyk-Saczonek, A | 1 |
| Kasprowicz-Furmańczyk, M | 1 |
| Kuna, J | 1 |
| Klimek, P | 1 |
| Krajewska-Włodarczyk, M | 1 |
| Ratajczak-Enselme, M | 1 |
| Mutoni, GC | 1 |
| Desmeules, J | 1 |
| Favet, L | 1 |
| Ing Lorenzini, K | 1 |
| Dagostin, MA | 2 |
| Caparbo, VF | 2 |
| Martins, CCMF | 2 |
| Barbas, CV | 2 |
| Benarous, X | 1 |
| Brocheton, C | 1 |
| Bonnay, C | 1 |
| Boissel, L | 1 |
| Crovetto, C | 1 |
| Lahaye, H | 1 |
| Guilé, JM | 1 |
| Theret, P | 1 |
| Gondry, J | 1 |
| Foulon, A | 1 |
| Kim, E | 1 |
| Yoo, SH | 1 |
| Chen, Z | 1 |
| Sousa, JA | 1 |
| Batista, E | 1 |
| Demeyer, S | 1 |
| Fischer, N | 1 |
| Pellegrino, O | 1 |
| Ribeiro, AS | 1 |
| Martins, LL | 1 |
| Worthy, FR | 1 |
| Goldberg, SD | 1 |
| Ranjitkar, S | 1 |
| Xu, JC | 1 |
| Asmara, AAGY | 1 |
| Karna, MB | 1 |
| Meregawa, PF | 1 |
| Deslivia, MF | 1 |
| Carula, BC | 1 |
| Giostri, GS | 1 |
| Bebber, F | 1 |
| Batista, MFDS | 1 |
| Silva, FBD | 1 |
| Novak, EM | 1 |
| Vilela, JCS | 1 |
| Franco, N | 1 |
| Campos, G | 1 |
| Deligne, LM | 1 |
| Machado, TLA | 1 |
| Degasperi, FA | 1 |
| Scatigna, BF | 1 |
| Falótico, GG | 1 |
| Romero, V | 1 |
| Basile, R | 1 |
| Takata, ET | 1 |
| Kaleka, CC | 1 |
| Debieux, P | 1 |
| Antonioli, E | 1 |
| Zucconi, E | 1 |
| Cohen, M | 1 |
| Ferretti, M | 1 |
| Bampidis, V | 2 |
| Azimonti, G | 2 |
| Bastos, ML | 2 |
| Christensen, H | 2 |
| Fašmon Durjava, M | 2 |
| Kouba, M | 2 |
| López-Alonso, M | 2 |
| López Puente, S | 2 |
| Marcon, F | 2 |
| Mayo, B | 2 |
| Pechová, A | 2 |
| Petkova, M | 2 |
| Ramos, F | 2 |
| Sanz, Y | 2 |
| Villa, RE | 2 |
| Woutersen, R | 2 |
| Brantom, P | 2 |
| Chesson, A | 2 |
| Westendorf, J | 2 |
| Manini, P | 2 |
| Pizzo, F | 2 |
| Dusemund, B | 2 |
| Aron, J | 1 |
| Albert, PS | 1 |
| Gribble, MO | 1 |
| Samankul, A | 1 |
| Senawong, G | 1 |
| Swatsitang, P | 1 |
| Sripa, B | 1 |
| Phaosiri, C | 1 |
| Kanokmedhakul, S | 1 |
| Senawong, T | 1 |
| Sirajudeen, MS | 1 |
| Alzhrani, M | 1 |
| Alanazi, A | 1 |
| Alqahtani, M | 1 |
| Waly, M | 1 |
| Unnikrishnan, R | 1 |
| Muthusamy, H | 1 |
| Alrubaia, W | 1 |
| Alanazi, N | 1 |
| Seyam, MK | 1 |
| Kashoo, F | 1 |
| Miraj, M | 1 |
| Channmgere Govindappa, S | 1 |
| Alghamdi, KA | 1 |
| Al-Hussinan, NM | 1 |
| Wang, Z | 2 |
| Qu, T | 1 |
| Qi, H | 1 |
| Zhao, S | 1 |
| Shi, H | 2 |
| Bai, W | 1 |
| Yu, Y | 1 |
| Zhao, P | 1 |
| Yakubov, S | 1 |
| Stockerl, WJ | 1 |
| Tian, X | 1 |
| Shahin, A | 1 |
| Mandigma, MJP | 1 |
| Gschwind, RM | 1 |
| Barham, JP | 1 |
| Li, R | 1 |
| Jiang, D | 1 |
| Du, P | 1 |
| Yuan, C | 1 |
| Cui, X | 1 |
| Tang, Q | 1 |
| Zheng, J | 1 |
| Lu, K | 1 |
| Ren, X | 1 |
| Gao, S | 1 |
| Zhan, X | 1 |
| Ramgoolam, KH | 1 |
| Dolphin, AC | 1 |
| Shi, Q | 1 |
| Zhou, YJ | 1 |
| Fang, JG | 1 |
| Zhong, X | 1 |
| Chen, LZ | 1 |
| Hou, HZ | 1 |
| Ma, L | 1 |
| Feng, SZ | 1 |
| He, JW | 1 |
| Huang, R | 1 |
| Wang, YF | 1 |
| Guo, FL | 1 |
| Li, LJ | 2 |
| Ruan, XH | 2 |
| Fu, GM | 1 |
| Zhao, JZ | 2 |
| Hou, XK | 1 |
| Gao, M | 2 |
| Zheng, XQ | 2 |
| Zeng, Y | 1 |
| Huang, DM | 1 |
| Zhang, JM | 1 |
| Kang, M | 1 |
| Zhu, J | 1 |
| Xu, YJ | 1 |
| Li, SN | 1 |
| Lai, JM | 1 |
| Liu, JJ | 1 |
| Wen, S | 1 |
| Yan, HH | 1 |
| Cheng, R | 1 |
| Zhu, F | 1 |
| Gao, PF | 1 |
| Zou, HY | 1 |
| Huang, CZ | 1 |
| Wang, J | 2 |
| AbdElgawad, H | 1 |
| Zinta, G | 1 |
| Hornbacher, J | 1 |
| Papenbrock, J | 1 |
| Markakis, MN | 1 |
| Asard, H | 1 |
| Beemster, GTS | 1 |
| Fukushi, Y | 1 |
| Akamine, Y | 1 |
| Abumiya, M | 1 |
| Tozawa, N | 1 |
| Yamashita, T | 1 |
| Nara, M | 1 |
| Kameoka, Y | 1 |
| Takahashi, N | 1 |
| Miura, M | 1 |
| Qi, G | 1 |
| Yu, T | 1 |
| Guo, Z | 1 |
| Ma, K | 1 |
| Jin, Y | 1 |
| Lucon-Xiccato, T | 1 |
| Montalbano, G | 1 |
| Gatto, E | 1 |
| Frigato, E | 1 |
| D'Aniello, S | 1 |
| Bertolucci, C | 1 |
| Shi, W | 1 |
| Ge, N | 1 |
| Yu, S | 1 |
| Wu, J | 1 |
| Hu, T | 1 |
| Wei, J | 1 |
| Yan, X | 1 |
| Lin, K | 1 |
| Deng, T | 1 |
| Qu, H | 1 |
| Ou, H | 1 |
| Huang, Q | 1 |
| Gao, B | 1 |
| Li, X | 1 |
| Wei, N | 1 |
| von Haeften, K | 1 |
| Laarmann, T | 1 |
| Wabnitz, H | 1 |
| Möller, T | 1 |
| Gries, KJ | 1 |
| Hart, CR | 1 |
| Kunz, HE | 1 |
| Ryan, Z | 1 |
| Parvizi, M | 1 |
| Liu, Y | 1 |
| Dasari, S | 1 |
| Lanza, IR | 1 |
| Perez, HL | 1 |
| Andonian, C | 1 |
| Wan, KX | 1 |
| Potts, D | 1 |
| Gonzalez, P | 1 |
| Smith, I | 1 |
| Kavetska, O | 1 |
| Zamora-Abrahan, GT | 1 |
| Salido, EO | 1 |
| Lichauco, JJT | 1 |
| Gutierrez-Rubio, AKM | 1 |
| Rivera-Go, ICT | 1 |
| Cortez, KJC | 1 |
| Suilan, KEA | 1 |
| Villo, JGB | 1 |
| Del Rosario, AG | 1 |
| Gonzalez-García, R | 1 |
| Roma, JR | 1 |
| Rodríguez-García, M | 1 |
| Arranz, N | 1 |
| Ambrosioni, J | 1 |
| Bodro, M | 1 |
| Castel, MÁ | 1 |
| Cofan, F | 1 |
| Crespo, G | 1 |
| Diekmann, F | 1 |
| Farrero, M | 1 |
| Forner, A | 1 |
| LLigoña, A | 1 |
| Marcos, MÁ | 1 |
| Moreno, A | 1 |
| Ruiz, P | 1 |
| Soy, D | 1 |
| Brunet, M | 1 |
| Miró, JM | 1 |
| Tuset, M | 1 |
| Whelan, MG | 1 |
| Santacroce, L | 1 |
| Masto, L | 1 |
| Qian, G | 1 |
| Kowalski, E | 1 |
| Vanni, K | 1 |
| Kanjilal, S | 1 |
| Weinblatt, ME | 1 |
| Tedeschi, SK | 1 |
| Ferreira, VH | 1 |
| Ierullo, M | 1 |
| Mavandadnejad, F | 1 |
| Kurtesi, A | 1 |
| Hu, Q | 1 |
| Hardy, WR | 1 |
| Pinzon, N | 1 |
| Yotis, D | 1 |
| Gingras, AC | 1 |
| Belga, S | 1 |
| Shalhoub, S | 1 |
| Hébert, MJ | 1 |
| Kabbani, D | 1 |
| Romero-Cabello, R | 1 |
| Romero-Feregrino, R | 2 |
| Muñoz-Cordero, B | 1 |
| Sevilla-Fuentes, S | 1 |
| Khalayli, N | 1 |
| Omar, A | 1 |
| Kudsi, M | 1 |
| Kooistra, EJ | 1 |
| Dahm, K | 1 |
| van Herwaarden, AE | 1 |
| Gerretsen, J | 1 |
| Nuesch Germano, M | 1 |
| Mauer, K | 1 |
| Smeets, RL | 1 |
| van der Velde, S | 1 |
| van den Berg, MJW | 1 |
| van der Hoeven, JG | 1 |
| Aschenbrenner, AC | 1 |
| Schultze, JL | 1 |
| Ulas, T | 1 |
| Kox, M | 1 |
| Pickkers, P | 1 |
| Magder, LS | 1 |
| Fava, A | 1 |
| Goldman, D | 1 |
| Petri, MA | 1 |
| Scirocco, C | 1 |
| Ferrigno, S | 1 |
| Andreoli, L | 1 |
| Lomater, C | 1 |
| Moroni, L | 1 |
| Mosca, M | 1 |
| Raffeiner, B | 1 |
| Carrara, G | 1 |
| Rozza, D | 1 |
| Zanetti, A | 1 |
| Scirè, CA | 1 |
| Sebastiani, GD | 1 |
| Marx, D | 1 |
| Moulin, B | 1 |
| Fafi-Kremer, S | 1 |
| Benotmane, I | 1 |
| Gautier, G | 1 |
| Perrin, P | 1 |
| Caillard, S | 1 |
| Arpali, E | 1 |
| Akyollu, B | 1 |
| Yelken, B | 1 |
| Tekin, S | 1 |
| Turkmen, A | 1 |
| Kocak, B | 1 |
| O'Kelly, B | 1 |
| McGettrick, P | 1 |
| Angelov, D | 1 |
| Fay, M | 1 |
| McGinty, T | 1 |
| Cotter, AG | 1 |
| Sheehan, G | 1 |
| Lambert, JS | 1 |
| Bozzalla Cassione, E | 1 |
| Zanframundo, G | 1 |
| Biglia, A | 1 |
| Codullo, V | 1 |
| Montecucco, C | 1 |
| Cavagna, L | 1 |
| Brancatella, A | 1 |
| Ricci, D | 1 |
| Viola, N | 1 |
| Sgrò, D | 1 |
| Santini, F | 1 |
| Latrofa, F | 1 |
| Mayor-Ibarguren, A | 1 |
| Feito-Rodriguez, M | 1 |
| Quintana Castanedo, L | 1 |
| Ruiz-Bravo, E | 1 |
| Montero Vega, D | 1 |
| Herranz-Pinto, P | 1 |
| Al-Adely, S | 1 |
| Danila, MI | 1 |
| Gossec, L | 1 |
| Katz, P | 1 |
| Rush, S | 1 |
| Schmajuk, G | 1 |
| Simard, J | 1 |
| Trupin, L | 1 |
| Wysham, KD | 1 |
| Hausmann, JS | 1 |
| Liew, JW | 1 |
| Sánchez-Velázquez, A | 2 |
| Falkenhain, D | 1 |
| Rivera Díaz, R | 1 |
| Novi, G | 1 |
| Rossi, T | 1 |
| Pedemonte, E | 1 |
| Saitta, L | 1 |
| Rolla, C | 1 |
| Roccatagliata, L | 1 |
| Inglese, M | 1 |
| Farinini, D | 1 |
| Modi, AR | 1 |
| Koval, CE | 1 |
| Taege, AJ | 1 |
| Modaresi Esfeh, J | 1 |
| Eghtesad, B | 1 |
| Narayanan Menon, KV | 1 |
| Quintini, C | 1 |
| Miller, C | 1 |
| Serrano, OK | 1 |
| Kutzler, HL | 1 |
| Rochon, C | 1 |
| Radojevic, JA | 1 |
| Lawlor, MT | 1 |
| Hammond, JA | 1 |
| Gluck, J | 1 |
| Feingold, AD | 1 |
| Jaiswal, A | 1 |
| Falkenhain-López, D | 1 |
| Agud-Dios, M | 1 |
| Ortiz-Romero, PL | 1 |
| Ruhl, DS | 1 |
| Hohman, MH | 1 |
| Kadono, Y | 1 |
| Nakamura, Y | 1 |
| Ogawa, Y | 1 |
| Yamamoto, S | 1 |
| Kajikawa, R | 1 |
| Nakajima, Y | 1 |
| Matsumoto, M | 1 |
| Kishima, H | 1 |
| Chen, TY | 1 |
| Farghaly, S | 1 |
| Cham, S | 1 |
| Tatem, LL | 1 |
| Sin, JH | 1 |
| Rauda, R | 1 |
| Ribisi, M | 1 |
| Sumrani, N | 1 |
| Zhou, S | 1 |
| Jones-Lopez, EC | 1 |
| Soneji, DJ | 1 |
| Azevedo, CJ | 1 |
| Patel, VR | 1 |
| Singh, S | 1 |
| Govindarajan, R | 1 |
| Hassan, K | 1 |
| Saiz-Rodríguez, M | 1 |
| Peña, T | 1 |
| Lázaro, L | 1 |
| González, Á | 1 |
| Martínez, A | 1 |
| Cordero, JA | 1 |
| Vicente, JT | 1 |
| Richard, F | 1 |
| Coma, MJ | 1 |
| de Frutos, M | 1 |
| Labrador, J | 1 |
| Pueyo, A | 1 |
| Ruggeri, RM | 1 |
| Campennì, A | 1 |
| Siracusa, M | 1 |
| Frazzetto, G | 1 |
| Gullo, D | 1 |
| Liaquat, H | 1 |
| Shupp, B | 1 |
| Kapoor, S | 1 |
| Matin, A | 1 |
| Varotti, G | 1 |
| Dodi, F | 1 |
| Garibotto, G | 1 |
| Fontana, I | 1 |
| He, F | 1 |
| Luo, Q | 1 |
| Lei, M | 1 |
| Fan, L | 1 |
| Shao, X | 1 |
| Hu, K | 1 |
| Qin, S | 1 |
| Yu, N | 1 |
| Cao, J | 1 |
| de la Cruz-Benito, B | 1 |
| Lázaro-Del Campo, P | 1 |
| Ramírez-López, A | 1 |
| de Soto-Álvarez, T | 1 |
| Sánchez-Vadillo, I | 1 |
| García-Pérez, E | 1 |
| Dos Santos-Ortas, A | 1 |
| Humala-Barbier, K | 1 |
| López-de la Guía, A | 1 |
| Casado-Abad, G | 1 |
| Jiménez-Yuste, V | 1 |
| Canales-Albendea, M | 1 |
| Lee, WS | 1 |
| Margolskee, E | 1 |
| Dajti, E | 1 |
| Cristini, F | 1 |
| Tamanini, G | 1 |
| Cescon, M | 1 |
| Bazzoli, F | 1 |
| Tamè, M | 1 |
| Redondo-Sendino, Á | 1 |
| González Sánchez, IC | 1 |
| de Victoria Fernández, B | 1 |
| Ni, R | 1 |
| Xie, F | 1 |
| Lu, L | 1 |
| Ordás, CM | 1 |
| Villacieros-Álvarez, J | 1 |
| Pastor-Vivas, AI | 1 |
| Corrales-Benítez, Á | 1 |
| Goss, MB | 1 |
| Munoz, FM | 1 |
| Ruan, W | 1 |
| Galván, NTN | 1 |
| O'Mahony, CA | 1 |
| Rana, A | 1 |
| Cotton, RT | 1 |
| Moreno, NF | 1 |
| Heczey, AA | 1 |
| Leung, DH | 1 |
| Goss, JA | 1 |
| Cabrera Muras, A | 1 |
| Carmona-Abellán, MM | 1 |
| Collía Fernández, A | 1 |
| Uterga Valiente, JM | 1 |
| Antón Méndez, L | 1 |
| García-Moncó, JC | 1 |
| Lima, MA | 1 |
| Silva, MTT | 1 |
| Soares, CN | 1 |
| Coutinho, R | 1 |
| Oliveira, HS | 1 |
| Afonso, L | 1 |
| Espíndola, O | 1 |
| Leite, AC | 1 |
| Araujo, A | 1 |
| Nelson, C | 1 |
| Ishimine, P | 1 |
| Hayden, SR | 1 |
| Correia, M | 1 |
| Wardi, G | 1 |
| Li, Q | 1 |
| Cheng, Q | 1 |
| Zhao, Z | 1 |
| Dai, N | 1 |
| Zeng, L | 1 |
| Zhu, L | 1 |
| Guo, W | 1 |
| Li, C | 1 |
| Li, S | 1 |
| Shen, N | 1 |
| Ge, Q | 1 |
| Armesto, S | 1 |
| González Vela, C | 1 |
| Sánchez, J | 1 |
| Illaro, A | 1 |
| Mayorga, J | 1 |
| López Sundh, AE | 1 |
| Naharro Fernández, C | 1 |
| Palmou, N | 1 |
| Gómez-Fernández, C | 1 |
| González López, MA | 1 |
| González-Gay, MA | 1 |
| Trujillo, H | 1 |
| Fernández-Ruiz, M | 1 |
| Gutiérrez, E | 1 |
| Sevillano, Á | 1 |
| Caravaca-Fontán, F | 1 |
| Morales, E | 1 |
| López-Medrano, F | 1 |
| Aguado, JM | 1 |
| Praga, M | 1 |
| Andrés, A | 1 |
| Tard, C | 1 |
| Maurage, CA | 1 |
| de Paula, AM | 1 |
| Cassim, F | 1 |
| Delval, A | 1 |
| Kuchcinski, G | 1 |
| Davion, JB | 1 |
| Defebvre, L | 1 |
| Bouchiba, M | 1 |
| Jourdain, M | 1 |
| Boucraut, J | 1 |
| Manzano, GS | 1 |
| Woods, JK | 1 |
| Amato, AA | 1 |
| Gálvez-Romero, JL | 1 |
| Palmeros-Rojas, O | 1 |
| Real-Ramírez, FA | 1 |
| Sánchez-Romero, S | 1 |
| Tome-Maxil, R | 1 |
| Ramírez-Sandoval, MP | 1 |
| Olivos-Rodríguez, R | 1 |
| Flores-Encarnación, SE | 1 |
| Cabrera-Estrada, AA | 1 |
| Ávila-Morales, J | 1 |
| Cortés-Sánchez, V | 1 |
| Sarmiento-Padilla, G | 1 |
| Tezmol-Ramírez, SE | 1 |
| Aparicio-Hernández, D | 1 |
| Urbina-Sánchez, MI | 1 |
| Gómez-Pluma, MÁ | 1 |
| Cisneros-Méndez, S | 1 |
| Rodríguez-Rivas, DI | 1 |
| Reyes-Inurrigarro, S | 1 |
| Cortés-Díaz, G | 1 |
| Cruz-Delgado, C | 1 |
| Navarro-González, J | 1 |
| Deveaux-Homs, J | 1 |
| Pedraza-Sánchez, S | 1 |
| Chern, A | 1 |
| Famuyide, AO | 1 |
| Moonis, G | 1 |
| Lalwani, AK | 1 |
| Tran, VT | 2 |
| Mahévas, M | 2 |
| Bani-Sadr, F | 1 |
| Robineau, O | 1 |
| Perpoint, T | 1 |
| Perrodeau, E | 2 |
| Gallay, L | 2 |
| Ravaud, P | 1 |
| Goehringer, F | 1 |
| Lescure, FX | 2 |
| Vechi, HT | 1 |
| Maia, LR | 1 |
| Alves, MDM | 1 |
| Rodrigues-Neto, JF | 1 |
| Bolaman, AZ | 1 |
| Selim, C | 1 |
| Karaman, C | 1 |
| Yavaşoğlu, İ | 1 |
| Nicod, LP | 1 |
| Yadav, SP | 1 |
| Wadhwa, T | 1 |
| Thakkar, D | 1 |
| Kapoor, R | 1 |
| Rastogi, N | 1 |
| Sarma, S | 1 |
| Winkler, A | 1 |
| Zitt, E | 1 |
| Sprenger-Mähr, H | 1 |
| Soleiman, A | 1 |
| Cejna, M | 1 |
| Lhotta, K | 1 |
| Singh, AD | 1 |
| Mian, A | 1 |
| Stoller, JK | 1 |
| Vignier, N | 1 |
| Bisio, F | 1 |
| Forestier, E | 1 |
| Lebedev, L | 1 |
| Sapojnikov, M | 1 |
| Wechsler, A | 1 |
| Varadi-Levi, R | 1 |
| Zamir, D | 1 |
| Tobar, A | 1 |
| Levin-Iaina, N | 1 |
| Fytlovich, S | 1 |
| Yagil, Y | 1 |
| Das, A | 1 |
| Rana, S | 1 |
| Veyseh, M | 1 |
| Koyoda, S | 1 |
| Ayesha, B | 1 |
| Bril, F | 1 |
| Al Diffalha, S | 1 |
| Dean, M | 1 |
| Fettig, DM | 1 |
| Wasser, LM | 1 |
| Roditi, E | 1 |
| Zadok, D | 1 |
| Berkowitz, L | 1 |
| Weill, Y | 1 |
| Raess, N | 1 |
| Schuetz, P | 1 |
| Cesana-Nigro, N | 1 |
| Winzeler, B | 1 |
| Urwyler, SA | 1 |
| Schaedelin, S | 1 |
| Rodondi, N | 1 |
| Blum, MR | 1 |
| Briel, M | 1 |
| Mueller, B | 1 |
| Christ-Crain, M | 1 |
| Blum, CA | 1 |
| Babu, TA | 1 |
| Sarkar, MK | 1 |
| Sharmila, V | 1 |
| Trotman, J | 1 |
| Pettitt, AR | 1 |
| Golding, B | 1 |
| Lee, Y | 1 |
| Golding, H | 1 |
| Khurana, S | 1 |
| O'Byrne, L | 1 |
| Webster, KE | 1 |
| MacKeith, S | 1 |
| Philpott, C | 1 |
| Hopkins, C | 1 |
| Burton, MJ | 1 |
| Ghielmetti, M | 1 |
| Schaufelberger, HD | 1 |
| Mieli-Vergani, G | 1 |
| Cerny, A | 1 |
| Dayer, E | 1 |
| Vergani, D | 1 |
| Terziroli Beretta-Piccoli, B | 1 |
| Izmirly, PM | 1 |
| Kim, MY | 1 |
| Samanovic, M | 1 |
| Fernandez-Ruiz, R | 1 |
| Ohana, S | 1 |
| Deonaraine, KK | 1 |
| Engel, AJ | 1 |
| Masson, M | 1 |
| Xie, X | 1 |
| Cornelius, AR | 1 |
| Herati, RS | 1 |
| Haberman, RH | 1 |
| Scher, JU | 1 |
| Guttmann, A | 1 |
| Blank, RB | 1 |
| Plotz, B | 1 |
| Haj-Ali, M | 1 |
| Banbury, B | 1 |
| Stream, S | 1 |
| Hasan, G | 1 |
| Ho, G | 1 |
| Rackoff, P | 1 |
| Blazer, AD | 1 |
| Tseng, CE | 1 |
| Belmont, HM | 1 |
| Saxena, A | 1 |
| Mulligan, MJ | 1 |
| Clancy, RM | 1 |
| Buyon, JP | 1 |
| Buddingh, EP | 1 |
| Vossen, ACTM | 1 |
| Lamb, HJ | 1 |
| van der Palen, RLF | 1 |
| Brinkman, DMC | 1 |
| Queler, SC | 1 |
| Towbin, AJ | 1 |
| Milani, C | 1 |
| Whang, J | 1 |
| Sneag, DB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Immunogenicity and Safety of the CoronaVac Vacccine in Patients With Autoimmune Rheumatic Diseases and People Living With HIV/AIDS[NCT04754698] | Phase 4 | 2,067 participants (Anticipated) | Interventional | 2021-02-09 | Active, not recruiting | ||
| Thyroid Function Tests and the Status of Thyroid Autoantibodies in Hospitalized Covid-19 Patients and Their Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer[NCT04659200] | 20 participants (Actual) | Observational | 2020-09-01 | Completed | |||
| A Three-arm, Multicenter, Open-label Randomized Controlled Trial of Hydroxychloroquine and Low-dose Prednisone on Recurrent Spontaneous Abortion With Undifferentiated Connective Tissue Diseases: Protocol for the Immunosuppressant Regimens for Living FEtus[NCT03671174] | 420 participants (Anticipated) | Interventional | 2019-08-02 | Recruiting | |||
| Effect of Short-Term Prednisone Therapy on C-reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers[NCT05916586] | 120 participants (Anticipated) | Interventional | 2023-08-11 | Recruiting | |||
| Smell in Covid-19 and Efficacy of Nasal Theophylline[NCT04789499] | Phase 2 | 51 participants (Actual) | Interventional | 2021-03-15 | Completed | ||
| Efficacy and Safety of Phototherapy in the Treatment of Loss of Smell Post Acute Infection of Coronavirus 19[NCT05177445] | 40 participants (Anticipated) | Interventional | 2022-04-30 | Not yet recruiting | |||
| Coronavirus Disease 2019- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ) Research Study A Randomized, Open Label Single Center Study[NCT04342728] | 214 participants (Actual) | Interventional | 2020-04-08 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The SF-36 is a well-established 36-item questionnaire evaluating physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. This test allows us to study the overall quality of life for those suffering from COVID-19 related OD. There is no single overall score for SF-36. The SF 36 generates 8 subscales with scores ranging from 0 (worst) to 100 (best). General health domain scores are reported here. (NCT04789499)
Timeframe: Baseline assessment
| Intervention | score on a scale (Median) |
|---|---|
| Theophylline | 75 |
| Placebo | 80 |
Questionnaire for Olfactory Dysfunction (QOD) assesses health-related quality of life of participants based on four factors such as eating, mental health, social interactions, or fear of dysfunction.. The survey also includes questions on parosmia, a phenomena of COVID-related OD. The QOD consists of 17 statements that participants score from 0-3, resulting in a total score from 0 to 51. Higher scores reflect better olfactory-specific QOL. (NCT04789499)
Timeframe: Comparison at 6 weeks post-intervention from baseline
| Intervention | score on a scale (Median) |
|---|---|
| Theophylline | 0.86 |
| Placebo | 1.43 |
The ODOR is a 28-item QOL instrument with a total score ranging from 0 to 112 points. Higher scores indicate worse QOL with higher degree of dysfunction and limitation. A decrease of 15 or more points is deemed to be a clinically significant improvement in QOL. (NCT04789499)
Timeframe: Comparison of response rate at 6 weeks post-intervention from baseline between the 2 study groups
| Intervention | score on a scale (Median) |
|---|---|
| Theophylline | -6.5 |
| Placebo | -4.5 |
"UPSIT 0-40 with higher scores indicating better smell.~This test is an objective, clinically validated 40-question forced-choice odor identification test where microencapsulated odorants on a strip are released by scratching. Out of a total of 40 points, normosmia is defined as ≥34 for males and ≥35 for females, and an increase in ≥4 points will be deemed a clinically significant improvement in symptoms." (NCT04789499)
Timeframe: Comparison at 6 weeks post-intervention from baseline
| Intervention | score on a scale (Median) |
|---|---|
| Theophylline | 3 |
| Placebo | 0 |
"UPSIT 0-40 with higher scores indicating better results.~The response rate defined as the number of participants in each group self-reporting of at least slightly better improvement in the Clinical Global Improvement Scale at 6 weeks post intervention as compared to baseline, devided by the total number of participants in that specific group. The CGI-Improvement Scale has seven response options (from 1 as Very Much Improved to 7 as Very Much Worsened) for answers to the question Compared to your sense of smell before you started the nasal irrigations, how would you rate your sense of smell now . Participants reporting 3 as Minimally Improved, 2 as Much Improved, or 1 as Very Much Improved in the CGI-I will be deemed responders to treatment, and the rate of responders will be compared between the two arms." (NCT04789499)
Timeframe: Comparison of response rate at 6 weeks post-intervention from baseline between the 2 study groups
| Intervention | percentage of participants (Number) |
|---|---|
| Theophylline | 59 |
| Placebo | 43 |
9 reviews available for prednisone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes | 2021 |
The physical exam's role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; COVID-19; Cyclophosphamide; Doxorubicin; Huma | 2023 |
Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies, | 2023 |
Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; COVID-19; COVID-19 Drug Treatment; D | 2020 |
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Labo | 2020 |
Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature.
Topics: Adolescent; Blood Sedimentation; C-Reactive Protein; Coronary Aneurysm; COVID-19; COVID-19 Drug Trea | 2020 |
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
Topics: Acute Kidney Injury; Administration, Inhalation; Amphotericin B; Anti-Bacterial Agents; Antibodies, | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
Topics: Administration, Oral; Ambroxol; Betamethasone; Bias; COVID-19; Expectorants; Glucocorticoids; Humans | 2021 |
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
Topics: 2019-nCoV Vaccine mRNA-1273; Animals; Antibodies, Antinuclear; Antibody Specificity; Autoantibodies; | 2021 |
6 trials available for prednisone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Axial Spondyloarthritis; COVID-19; COVID-19 Vaccines; Fe | 2023 |
Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies, | 2023 |
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Ambulatory Care; Antiviral Agents; Betacoronavirus | 2020 |
A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIv
Topics: Abortion, Habitual; COVID-19; Female; Fetus; Humans; Hydroxychloroquine; Immunosuppressive Agents; M | 2020 |
Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study.
Topics: COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; | 2021 |
Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial.
Topics: Aged, 80 and over; Analysis of Variance; Biomarkers, Pharmacological; C-Reactive Protein; Community- | 2021 |
84 other studies available for prednisone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Urticaria and angioedema associated with SARS-CoV-2 infection.
Topics: Adult; Angioedema; Anti-Allergic Agents; COVID-19; Humans; Male; Prednisone; SARS-CoV-2; Treatment O | 2021 |
Presumed Recurrent MEWDS following Covid-19 Vaccination.
Topics: COVID-19; COVID-19 Vaccines; Female; Fluorescein Angiography; Glucocorticoids; Humans; Middle Aged; | 2021 |
Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study.
Topics: COVID-19; Cytokines; Humans; Immunity; Immunosuppression Therapy; Leukocytes, Mononuclear; Mycopheno | 2021 |
Stridor Due to Cranial Nerve X Palsy Progressing to Polyneuropathy in a Teenager With COVID-19.
Topics: Acute Disease; Adolescent; Combined Modality Therapy; COVID-19; Deglutition Disorders; Diagnosis, Di | 2021 |
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antibody Formation; Antigens, CD20; Anti | 2022 |
Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; COVID-19; COVID-19 Drug Treatm | 2022 |
Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination.
Topics: Autoantibodies; Autoimmune Diseases; BNT162 Vaccine; Cognitive Dysfunction; COVID-19; Encephalitis; | 2021 |
Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Arthritis, Rheum | 2022 |
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Topics: COVID-19; Humans; Lupus Erythematosus, Systemic; Male; Prednisone; Rheumatology; Severity of Illness | 2022 |
Transition to Virtual Asthma Care During the COVID-19 Pandemic: An Observational Study.
Topics: Adult; Anti-Asthmatic Agents; Asthma; COVID-19; Humans; Pandemics; Prednisone; Retrospective Studies | 2022 |
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Topics: Adult; Antibodies, Viral; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Female; Humans; Immunoge | 2022 |
Non-arteritic Anterior Ischemic Optic Neuropathy with Macular Star following COVID-19 Vaccination.
Topics: BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; | 2022 |
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymp | 2022 |
Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database.
Topics: Adrenal Cortex Hormones; COVID-19; COVID-19 Vaccines; Hospital Mortality; Hospitalization; Humans; I | 2022 |
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
Topics: Antibodies, Viral; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; Prednisone | 2022 |
COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: mental health issues and life conditions.
Topics: Adolescent; Arthritis, Juvenile; Child; COVID-19; Cross-Sectional Studies; Dermatomyositis; Female; | 2022 |
Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients.
Topics: Adult; Antibodies, Viral; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; mRN | 2022 |
Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marro | 2022 |
A case report of possible concurrent vasculitis in vertebral bodies and partial transverse myelitis following COVID-19 vaccination.
Topics: Adult; COVID-19; COVID-19 Vaccines; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; My | 2022 |
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients.
Topics: Abatacept; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunog | 2022 |
Aseptic Abscess Syndrome in Rheumatoid Arthritis Patient.
Topics: Abscess; Adalimumab; Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Arthritis, Rheumatoid; CO | 2022 |
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine.
Topics: Aged; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Male; Prednisone; Purpura, Thrombocytopen | 2023 |
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Viral; COVID-19; Humans; Imm | 2023 |
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Viral; COVID-19; Humans; Imm | 2023 |
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Viral; COVID-19; Humans; Imm | 2023 |
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Viral; COVID-19; Humans; Imm | 2023 |
Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective.
Topics: Adult; Arthritis, Rheumatoid; COVID-19; Female; Heart Diseases; Humans; Hypertension; Lupus Erythema | 2023 |
Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir.
Topics: COVID-19; COVID-19 Drug Treatment; Drug Interactions; Humans; Lopinavir; Organ Transplantation; Pred | 2023 |
Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination.
Topics: Antibodies, Viral; Antibody Formation; Antirheumatic Agents; COVID-19; COVID-19 Vaccines; Cross-Sect | 2023 |
Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study.
Topics: Antibodies, Neutralizing; Antibodies, Viral; Breakthrough Infections; Cohort Studies; COVID-19; Fema | 2023 |
Outpatient treatment of COVID-19: an experience with 552 cases in Mexico.
Topics: Azithromycin; COVID-19; Humans; Mexico; Outpatients; Prednisone; SARS-CoV-2; Treatment Outcome | 2023 |
Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report.
Topics: Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Female; Humans; Middle Aged; Pemphigus; Prednisone | 2023 |
Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19.
Topics: COVID-19; Dexamethasone; Disease Progression; Humans; Idiopathic Pulmonary Fibrosis; Prednisone; Res | 2023 |
Does the use of corticosteroids and immunosuppressants increase the risk of COVID-19 infection among people with systemic lupus erythematosus?
Topics: Adrenal Cortex Hormones; COVID-19; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; | 2023 |
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
Topics: Aged; Arthritis, Rheumatoid; COVID-19; Female; Humans; Hypertension; Lupus Erythematosus, Systemic; | 2023 |
First case of COVID-19 in a kidney transplant recipient treated with belatacept.
Topics: Abatacept; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Immunosuppression Therapy; Immuno | 2020 |
Case report: A kidney transplant patient with mild COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Tre | 2020 |
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Labora | 2020 |
Subacute Thyroiditis After Sars-COV-2 Infection.
Topics: Adolescent; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID | 2020 |
Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report.
Topics: Aged, 80 and over; Biopsy, Needle; Coronavirus Infections; COVID-19; Female; Follow-Up Studies; Huma | 2020 |
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agent | 2020 |
[Erythema multiforme in the context of SARS-Coronavirus-2 infection].
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Causality; Coronavir | 2020 |
Acute disseminated encephalomyelitis after SARS-CoV-2 infection.
Topics: Ageusia; Brain; Coronavirus Infections; COVID-19; Encephalomyelitis, Acute Disseminated; Evoked Pote | 2020 |
Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
Topics: Antibiotics, Antineoplastic; Bacteremia; BK Virus; Cardiomyopathy, Dilated; Cardiotoxicity; COVID-19 | 2020 |
COVID-19-related acute genital ulcers.
Topics: Adult; COVID-19; COVID-19 Testing; Diagnosis, Differential; Female; Genital Diseases, Female; Glucoc | 2020 |
An Example of Employing the Principles of Bioethics to Medical Decision Making in the COVID-19 Era.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Bell Palsy; Bioethics; Clinical Decision-Making; COVID-1 | 2020 |
A case of COVID-19 infection presenting with a seizure following severe brain edema.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Azithromycin; Betacoronavirus; Brain | 2020 |
COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
Topics: Acute Kidney Injury; Adult; Aged; Azithromycin; Calcineurin Inhibitors; COVID-19; COVID-19 Nucleic A | 2020 |
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.
Topics: Adult; Autoantibodies; Betacoronavirus; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; M | 2020 |
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.
Topics: Adult; Betacoronavirus; Cholinesterase Inhibitors; Coronavirus Infections; COVID-19; Disease Progres | 2020 |
Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection.
Topics: Angioedema; Anti-Allergic Agents; Betacoronavirus; Chlorpheniramine; Coronavirus Infections; COVID-1 | 2020 |
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Viral; COVID-19; Female; Humans; Immunoglobulin G; Immu | 2021 |
High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Autoimmune Pancreatitis; Betacoronavirus; Coronavirus Infections; COVID-19; Dose-Response Relationsh | 2020 |
Successful kidney transplantation after COVID-19.
Topics: Adult; Antibodies, Viral; Bacteremia; Basiliximab; Combined Modality Therapy; COVID-19; COVID-19 Tes | 2020 |
Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocol | 2020 |
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
Topics: Anti-Inflammatory Agents; Aspirin; Betacoronavirus; Child; Clinical Laboratory Techniques; Coronavir | 2020 |
COVID-19 in a young liver transplant recipient: caution for drug-drug interactions.
Topics: Acute Kidney Injury; Adult; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coron | 2020 |
[Skin manifestations associated with the new coronavirus SARS-CoV-2 disease].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Benzimidazoles; Betacoronavirus; Betamethasone; Causalit | 2020 |
Concurrent tonic pupil and trochlear nerve palsy in COVID-19.
Topics: Anti-Inflammatory Agents; COVID-19; Diplopia; Humans; Male; Middle Aged; Prednisone; SARS-CoV-2; Ton | 2020 |
Liver transplant in a recently COVID-19 positive child with hepatoblastoma.
Topics: Child, Preschool; COVID-19; COVID-19 Testing; Disease Progression; Hepatoblastoma; Humans; Immunoglo | 2021 |
Bilateral facial nerve palsy associated with COVID-19 and Epstein-Barr virus co-infection.
Topics: Anti-Inflammatory Agents; COVID-19; Epstein-Barr Virus Infections; Facial Paralysis; Humans; Magneti | 2021 |
Peripheral facial nerve palsy associated with COVID-19.
Topics: Adult; Anti-Inflammatory Agents; COVID-19; Facial Nerve; Facial Paralysis; Female; Humans; Male; Met | 2020 |
Novel coronavirus infection and acute kidney injury in two renal transplant recipients: a case report.
Topics: Acute Kidney Injury; Adult; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration S | 2020 |
Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic.
Topics: Adult; Antibodies, Monoclonal, Humanized; COVID-19; Drug Resistance, Multiple; Drug Therapy, Combina | 2020 |
Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy.
Topics: Aged; Autoantibodies; Autoantigens; Betacoronavirus; Cell Adhesion Molecules; Combined Modality Ther | 2020 |
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
Topics: Adenosine Monophosphate; Adult; Alanine; COVID-19; Humans; Interferon Type I; Male; Methylprednisolo | 2020 |
Bilateral Sudden Sensorineural Hearing Loss and Intralabyrinthine Hemorrhage in a Patient With COVID-19.
Topics: Adolescent; Anti-Inflammatory Agents; COVID-19; Dexamethasone; Female; Hearing Loss, Bilateral; Hear | 2021 |
Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; C-Reactive Protein; COVID-19; C | 2021 |
Favorable outcome of COVID-19 in a young woman with severe Crohn's disease on regular use of adalimumab and prednisone: a case report.
Topics: Adalimumab; COVID-19; Crohn Disease; Female; Humans; Prednisone; Tumor Necrosis Factor Inhibitors | 2020 |
Masquerading of COVID-19 Infection as Primary Mediastinal Large B-Cell Lymphoma
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; COVID-19; COVID-19 Drug Treatment; Cyclophosp | 2021 |
Topics: COVID-19; Humans; Lung; Lung Diseases, Interstitial; Prednisone; Prospective Studies; SARS-CoV-2; Sw | 2021 |
COVID-19 reinfection in two children with cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Child, Presch | 2021 |
SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report.
Topics: Anti-Glomerular Basement Membrane Disease; Child; COVID-19; Cyclophosphamide; Female; Glucocorticoid | 2021 |
Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?
Topics: COVID-19; Duration of Therapy; Humans; Male; Middle Aged; Prednisone; Pulmonary Disease, Chronic Obs | 2021 |
Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Franc | 2021 |
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Topics: Acute Kidney Injury; Biopsy; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Creatinine; Edema; Glucoco | 2021 |
The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.
Topics: Binding Sites; Complement C5a; COVID-19; COVID-19 Drug Treatment; Gene Expression Regulation; Humans | 2021 |
COVID-19 IgG-related autoimmune inflammatory necrotizing myositis.
Topics: Antibodies, Viral; Autoimmune Diseases; COVID-19; Diagnosis, Differential; Female; Humans; Immunoglo | 2021 |
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?
Topics: Adult; Antibodies, Antinuclear; Biopsy; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; DNA; Endosonogr | 2021 |
Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine.
Topics: Acute Disease; Administration, Ophthalmic; Administration, Oral; Aged; BNT162 Vaccine; COVID-19; COV | 2021 |
COVID-19 vestibular neuritis (CVN) in a healthcare worker: a rare complication of COVID-19 infection.
Topics: COVID-19; Female; Health Personnel; Humans; Nausea; Prednisone; SARS-CoV-2; Treatment Outcome; Vesti | 2021 |
Is it time for PET-guided therapy in follicular lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; COVID-19; Cyclophosphamide; Doxorubicin; Fluorodeoxy | 2022 |
Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report.
Topics: Aged; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunocompro | 2021 |
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Ad26COVS1; Adult; Antibodies, Viral; Antirheumatic Agents; B-Lymphocyte | 2022 |
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in Children.
Topics: Adolescent; Biomarkers; COVID-19; Female; Humans; Immunoglobulins, Intravenous; Inflammation; Methyl | 2021 |
Parsonage-Turner Syndrome Following COVID-19 Vaccination: MR Neurography.
Topics: Adult; Analgesics; Brachial Plexus; Brachial Plexus Neuritis; COVID-19; COVID-19 Vaccines; Gabapenti | 2022 |